JOURNAL OF CLINICAL APHERESIS
Scope & Guideline
Exploring the Frontiers of Apheresis: Where Science Meets Care
Introduction
Aims and Scopes
- Therapeutic Apheresis Techniques:
The journal highlights various therapeutic apheresis methods, including therapeutic plasma exchange, leukapheresis, and immunoadsorption, focusing on their clinical applications for conditions such as autoimmune diseases, hematologic disorders, and organ transplant management. - Clinical Outcomes and Efficacy:
Research articles often evaluate the efficacy, safety, and clinical outcomes associated with different apheresis procedures, providing evidence-based insights that guide clinical practice and improve patient care. - Innovations in Apheresis Technology:
The journal explores advancements in apheresis technology, including new devices and techniques that enhance the efficiency and safety of procedures, thus contributing to the evolution of apheresis in clinical settings. - Patient-Centered Care:
Emphasis is placed on understanding patient experiences, tolerability, and outcomes related to apheresis treatments, aiming to improve the overall quality of care for patients undergoing these procedures. - Interdisciplinary Collaboration:
The journal promotes interdisciplinary research and collaboration among clinicians, researchers, and technologists in the field of apheresis, recognizing the importance of diverse perspectives in advancing the field.
Trending and Emerging
- COVID-19 Related Apheresis Applications:
Recent publications increasingly focus on the use of therapeutic apheresis in managing complications related to COVID-19, including the treatment of cytokine storms and the effectiveness of convalescent plasma therapy. - Personalized Apheresis Approaches:
There is a growing trend towards personalized apheresis approaches tailored to individual patient profiles, including genetic and immunological factors, enhancing the efficacy and safety of treatments. - Pediatric Apheresis Innovations:
An increasing number of studies are dedicated to pediatric apheresis, addressing unique challenges and innovations in performing apheresis in younger populations, which is crucial for optimizing care in this vulnerable group. - Integration of Apheresis with Other Therapies:
Emerging research explores the integration of apheresis with other therapeutic modalities, such as immunotherapy and targeted therapies, to enhance treatment outcomes for complex conditions. - Long-Term Outcomes and Quality of Life Studies:
There is a rising emphasis on studies that assess long-term outcomes and quality of life for patients undergoing apheresis, reflecting a broader focus on holistic patient care and post-treatment follow-up.
Declining or Waning
- Traditional Hemapheresis Techniques:
There has been a noticeable decline in studies focused on traditional hemapheresis methods, as newer technologies and techniques gain prominence in clinical practice, leading to reduced interest in established methods. - Generalized Apheresis Protocols:
The publication of generic apheresis protocols without specific clinical context or outcomes has decreased, suggesting a shift towards more tailored and condition-specific research. - Single-Center Studies:
There appears to be a waning emphasis on single-center studies, with a preference for multicenter collaborations that provide more robust data and insights applicable across diverse clinical settings. - Basic Research on Apheresis Mechanisms:
Research focusing solely on the basic mechanisms of apheresis without direct clinical application or implications is less frequently published, as the journal prioritizes studies that demonstrate clear clinical relevance.
Similar Journals
KOREAN JOURNAL OF INTERNAL MEDICINE
Exploring New Frontiers in Internal Medicine ScholarshipKorean Journal of Internal Medicine, ISSN 1226-3303, E-ISSN 2005-6648, published by the Korean Association of Internal Medicine, stands as a vital resource in the field of internal medicine. Since its inception in 1961 and the shift to open access in 1986, this journal has consistently provided a platform for innovative research and clinical practices, contributing significantly to the advancement of medical knowledge in South Korea and beyond. With an impressive 2023 impact factor and a Q2 quartile ranking among internal medicine journals, it occupies a commendable position in Scopus rankings, holding the #54 slot out of 167 in the category. The journal emphasizes the dissemination of high-quality research findings, clinical reviews, and case reports, making it indispensable for researchers, professionals, and students eager to stay at the forefront of internal medicine. For authors and readers alike, the journal fosters an engaged and informed community, supporting the continuing education and professional development necessary in today's rapidly evolving medical landscape.
Current Treatment Options in Neurology
Empowering Clinicians with Cutting-Edge Treatment StrategiesCurrent Treatment Options in Neurology, published by CURRENT MEDICINE GROUP, is a pivotal journal in the field of clinical neurology, dedicated to enhancing the understanding and management of neurological disorders. With a print ISSN of 1092-8480 and an E-ISSN of 1534-3138, this journal serves as a vital resource for clinicians, researchers, and students alike, providing evidence-based insights and treatment strategies from its continuous publication since its inception in 1999. It currently holds a respectable rank in the Q3 quartile, reflecting its competitive standing in the Scopus rankings for clinical neurology, placing it at the 51st percentile. Although not classified as Open Access, the journal continues to provide valuable contributions that inform clinical practices and improve patient outcomes in neurological care. With its comprehensive reviews and clinical focus, Current Treatment Options in Neurology remains an essential platform for disseminating the latest advancements in treatment methodologies and therapeutic options, solidifying its importance in the ever-evolving landscape of neurology.
RHEUMATOLOGY INTERNATIONAL
Connecting global experts in rheumatology and immunology.Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.
International Journal of Laboratory Hematology
Advancing the science of hematology through innovative research.The International Journal of Laboratory Hematology, published by WILEY, serves as a vital resource in the field of hematology, delivering high-quality research findings and innovations within laboratory practices since its inception in 2007. This journal, accessible under Open Access options, showcases cutting-edge studies that span critical aspects of biochemistry and clinical laboratory methodologies. With a notable impact factor reflected in its Q2 and Q3 rankings across various categories—such as Biochemistry (medical) and Hematology—this journal stands out within the Scopus rankings, positioning itself within the 60th and 59th percentiles of its respective fields. Situated in the United Kingdom, the journal's objectives lie in disseminating pivotal research that enhances our understanding of hematological disorders and laboratory techniques, making it an essential tool for researchers, professionals, and students alike who are committed to advancing the science of laboratory hematology and its applications.
World Journal of Clinical Cases
Empowering Healthcare Professionals with Quality Case ReportsThe World Journal of Clinical Cases is a premier publication dedicated to the dissemination of high-quality clinical research and case reports that contribute to enhancing clinical practice and patient care. Established by BAISHIDENG PUBLISHING GROUP INC, this journal has established itself as a significant resource in the field of medicine, achieving a Q3 ranking in the miscellaneous category as of 2021 and maintaining a competitive position with a Scopus rank of #443/826. With coverage from 2018 to 2023, the journal focuses on diverse aspects of general medicine, promoting innovative research and clinical insights. Although it is not listed as open access, researchers and practitioners can benefit from its focused scope, aiding in knowledge advancement and fostering collaborative efforts in the medical community. The journal's commitment to quality and integrity makes it an essential platform for professionals seeking to stay informed about the latest clinical developments.
Current Opinion in Allergy and Clinical Immunology
Empowering professionals with cutting-edge reviews and opinions.Current Opinion in Allergy and Clinical Immunology, published by Lippincott Williams & Wilkins, is a pivotal journal that serves as a key resource for professionals in the fields of immunology and allergy. With an ISSN of 1528-4050 and an E-ISSN of 1473-6322, this journal presents cutting-edge reviews of the latest research findings, methodologies, and therapeutic approaches in the management of allergic and immunological disorders. With a Q3 category ranking in both Immunology and Allergy for 2023, and a Scopus rank of #103 in Immunology and Allergy, it reflects a solid position within the scientific community. Operating in the highly dynamic fields of immunology and clinical practice since its inception in 2001, the journal aims to harmonize emerging research trends with clinical applications to enhance patient outcomes. Although it does not currently offer Open Access options, the journal's substantial impact factor attests to its significance as a scholarly resource. By disseminating high-quality reviews and expert opinions, Current Opinion in Allergy and Clinical Immunology continues to foster knowledge advancement and professional development among researchers, practitioners, and students alike.
TRANSFUSION MEDICINE AND HEMOTHERAPY
Advancing transfusion science for better patient outcomes.TRANSFUSION MEDICINE AND HEMOTHERAPY, published by KARGER, is a prominent journal dedicated to advancing the fields of hematology and transfusion medicine. With an ISSN of 1660-3796 and E-ISSN 1660-3818, this esteemed journal has been a valuable resource for researchers and clinicians since its inception in 1973, with significant publication phases continuing into 2024. It currently holds a Q2 ranking in Hematology and a Q3 ranking in Immunology and Allergy, reflecting its impact and relevance in these critical fields. The journal features original articles, reviews, and clinical studies, presenting cutting-edge research that aids in the development of effective therapies and enhances patient care. Open access options are available, ensuring that crucial findings are accessible to a broad audience. As an important platform for dialogue and advancement in transfusion science, TRANSFUSION MEDICINE AND HEMOTHERAPY supports the global health community's efforts to improve treatment outcomes and foster innovation in medical practices.
THERAPEUTIC APHERESIS AND DIALYSIS
Elevating clinical practice through groundbreaking research.THERAPEUTIC APHERESIS AND DIALYSIS is an esteemed journal published by Wiley, focusing on the fields of hematology and nephrology. Since its inception in 2003, the journal has provided a dedicated platform for research and advancements in therapeutic apheresis and dialysis methodologies, offering valuable insights for clinicians and researchers alike. With an ISSN of 1744-9979 and an E-ISSN of 1744-9987, the journal has established itself within Q3 in both the hematology and nephrology categories. Its Scopus rankings place it at #44 in nephrology and #79 in hematology, indicating its growing influence in these critical areas of medical research. Although it does not currently offer open access, THERAPEUTIC APHERESIS AND DIALYSIS remains a vital resource for professionals aiming to stay at the forefront of innovations and practices through 2024 and beyond. Researchers, healthcare professionals, and students are encouraged to engage with the latest findings and discussions presented within its pages, solidifying its role in enhancing patient care and therapeutic strategies.
British Journal of Pain
Advancing the Science of Pain ManagementThe British Journal of Pain is a leading publication in the field of Anesthesiology and Pain Medicine, expertly published by SAGE Publications Ltd from the United Kingdom. With an ISSN of 2049-4637 and an E-ISSN of 2049-4645, this journal has established itself as an essential resource for researchers and practitioners alike, achieving an impressive Q2 ranking in its category for 2023, as well as a Scopus rank of #53 out of 136 in Medicine – Anesthesiology and Pain Medicine. The journal spans a broad scope of topics related to pain management, therapeutic practices, and advancements in treatment methodologies, catering to both ongoing research and clinical applications. Researchers and professionals can access a wealth of knowledge that not only supports the academic community but also drives innovative practices in pain management. The British Journal of Pain recognizes the significance of evidence-based research and its application in clinical settings, making it a vital platform for advancing the understanding of pain and improving patient care.
Iraqi Journal of Hematology
Elevating Knowledge, Elevating CareIraqi Journal of Hematology is a prominent peer-reviewed open-access journal dedicated to advancing the field of hematology. Published by Wolters Kluwer Medknow Publications, this journal provides a platform for researchers, professionals, and students to share cutting-edge findings and developments in various aspects of hematology, including blood diseases, diagnostics, and innovative treatments. Since its transition to open access in 2016, the journal has significantly increased its reach, allowing for wider dissemination of critical research to a global audience. With an ISSN of 2072-8069 and an E-ISSN of 2543-2702, the Iraqi Journal of Hematology strives to adhere to the highest scholarly standards and plays a vital role in the ongoing discourse in hematological research. Researchers are encouraged to contribute to this essential resource for the scientific community, contributing to the advancement of knowledge that ultimately improves patient care and treatment outcomes.